STOCK TITAN

Invivyd to Participate at Cowen’s 43rd Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

On February 28, 2023, Invivyd, a clinical-stage biopharmaceutical company listed on Nasdaq under the ticker IVVD, announced that CEO David Hering will present at Cowen's 43rd Annual Healthcare Conference on March 6, 2023, at 2:10 p.m. ET. The presentation will be available as a live webcast and archived for 90 days on the company’s investor website. Invivyd focuses on combating viral respiratory diseases through innovative antibody development, particularly targeting COVID-19. The company aims to enhance natural immunity to provide superior viral protection.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases, today announced David Hering, chief executive officer of Invivyd, is scheduled to present at Cowen’s 43rd Annual Healthcare Conference on Monday, March 6, 2023 at 2:10 p.m. ET.

A live webcast of the presentation will be available in the investor section of the company's website at investors.invivyd.com and will be archived for 90 days following the presentation.

About Invivyd
(Nasdaq: IVVD)
Invivyd, Inc., formerly Adagio Therapeutics (Nasdaq: ADGI), is a biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases.​ The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. ​Invivyd’s technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify high-quality, long-lasting antibodies with a high barrier to viral escape.​ Visit www.invivyd.com to learn more.

Media Contact:
Kate Burdick, Evoke Canale
860-462-1569
kate.burdick@evokegroup.com

Investor Contact:
Chris Brinzey, ICR Westwicke
339-970-2843
chris.brinzey@westwicke.com


FAQ

What is the date and time of Invivyd's presentation at the Cowen Annual Healthcare Conference?

David Hering, CEO of Invivyd, will present on March 6, 2023, at 2:10 p.m. ET.

Where can I watch the Invivyd presentation from the Cowen Conference?

The presentation will be available as a live webcast on Invivyd's investor section of their website.

What is Invivyd's mission?

Invivyd aims to protect humanity from serious viral respiratory diseases through advanced antibody development.

What is the ticker symbol for Invivyd?

Invivyd trades under the ticker symbol IVVD on Nasdaq.

How long will the Invivyd presentation be archived?

The presentation will be archived for 90 days following the live event.

Invivyd, Inc.

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Stock Data

50.24M
96.19M
18.17%
79.25%
6.93%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
WALTHAM